SIX4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.28860000015285E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.77111708316625E-12 |
Normal-vs-Stage2 |
2.630100E-04 |
Normal-vs-Stage3 |
5.833500E-02 |
Normal-vs-Stage4 |
2.562500E-02 |
Stage1-vs-Stage2 |
5.906000E-01 |
Stage1-vs-Stage3 |
2.219800E-01 |
Stage1-vs-Stage4 |
3.424800E-01 |
Stage2-vs-Stage3 |
4.234400E-01 |
Stage2-vs-Stage4 |
5.239400E-01 |
Stage3-vs-Stage4 |
9.084800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.39500000018967E-07 |
Normal-vs-AfricanAmerican |
2.48220000109711E-08 |
Normal-vs-Asian |
1.844770E-01 |
Caucasian-vs-AfricanAmerican |
7.583000E-01 |
Caucasian-vs-Asian |
4.038400E-01 |
AfricanAmerican-vs-Asian |
9.842100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.96609999953057E-07 |
Normal-vs-Female |
3.784700E-03 |
Male-vs-Female |
7.340600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
7.8583000107102E-09 |
Normal-vs-Extreme_Weight |
4.02409999999964E-05 |
Normal-vs-Obese |
2.378900E-04 |
Normal-vs-Extreme_Obese |
4.388200E-04 |
Normal_Weight-vs-Extreme_Weight |
6.222200E-01 |
Normal_Weight-vs-Obese |
3.084200E-01 |
Normal_Weight-vs-Extreme_Obese |
9.865800E-01 |
Extreme_Weight-vs-Obese |
6.724800E-01 |
Extreme_Weight-vs-Extreme_Obese |
7.124800E-01 |
Obese-vs-Extreme_Obese |
4.367600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.442000E-01 |
Normal-vs-Age(41-60Yrs) |
1.8928000278251E-09 |
Normal-vs-Age(61-80Yrs) |
4.86829999979399E-07 |
Normal-vs-Age(81-100Yrs) |
4.93019958192065E-10 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.621700E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.194100E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.418300E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.490600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.397300E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.569780E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.21709999856279E-08 |
Normal-VS-Type2 PRCC |
8.61740012680912E-10 |
Normal-VS-KIRP CIMP |
1.072830E-01 |
Normal-VS-Unclassified PRCC |
3.41640000001142E-06 |
Type1 PRCC-VS-Type2 PRCC |
6.671200E-01 |
Type1 PRCC-VS-KIRP CIMP |
9.202600E-03 |
Type1 PRCC-VS-Unclassified PRCC |
2.346600E-01 |
Type2 PRCC-VS-KIRP CIMP |
8.680700E-03 |
Type2 PRCC-VS-Unclassified PRCC |
2.126000E-01 |
KIRP CIMP-VS-Unclassified PRCC |
1.376100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.23499999116206E-09 |
Normal-vs-N1 |
5.303600E-01 |
Normal-vs-N2 |
4.923600E-01 |
N0-vs-N1 |
2.565900E-02 |
N0-vs-N2 |
2.966800E-01 |
N1-vs-N2 |
9.504000E-01 |
|
|